Related Experiment Video
Updated: May 7, 2025

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Antibodies Against Phosphorylcholine in Prediction of Cardiovascular Disease Among Women: A Population-Based
Johan Frostegård1, Agneta Åkesson1, Emilie Helte1
1Units of Immunology and chronic disease, and Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Insights
Antibodies against phosphorylcholine (anti-PC) show protective effects against cardiovascular disease (CVD) in women. Higher IgM anti-PC levels were linked to a significantly reduced risk of myocardial infarction (MI), suggesting a role in CVD prevention.
Area of Science:
- Immunology
- Cardiovascular Science
- Epidemiology
Background:
- Antibodies against phosphorylcholine (anti-PC) are linked to protection against atherosclerosis, cardiovascular disease (CVD), and chronic inflammatory conditions.
- Potential mechanisms include anti-inflammatory effects, enhanced clearance of dead cells, and inhibition of oxidized low-density lipoprotein (oxLDL).
Purpose of the Study:
- To investigate the association between IgM anti-PC levels and the incidence of CVD in women.
- To explore sex-specific differences in the role of anti-PC in CVD risk, as less is known about women.
Main Methods:
- Serum IgM anti-PC levels were measured in 932 women from the Swedish Mammography Cohort using Enzyme Linked Immunosorbent assay (ELISA).
- Prospective associations with incident CVD, ischemic heart disease (IHD), myocardial infarction (MI), and ischemic stroke were analyzed using Cox proportional hazard regression.
- Models were adjusted for potential confounding factors.
Main Results:
- Over 16 years, 113 CVD cases, 69 IHD cases, 44 MI cases, and 50 ischemic stroke cases were identified.
- IgM anti-PC showed a statistically significant inverse association with the risk of CVD, IHD, and MI.
- The highest tertile of IgM anti-PC was associated with a multivariable-adjusted Hazard Ratio (HR) of 0.27 (95% CI: 0.11-0.68) for MI.
Conclusions:
- Elevated IgM anti-PC levels may play a protective role in the development of CVD in women, particularly MI.
- IgM anti-PC may serve as a potential biomarker for identifying women at increased risk of CVD.
Background:
Antibodies against phosphorylcholine (anti-PC) have been reported as associated with protection against atherosclerosis, cardiovascular disease (CVD), and other chronic inflammatory diseases. Underlying potential mechanisms have been demonstrated and include anti-inflammatory, clearance of dead cells, and inhibition of oxidized low-density lipoprotein effects.
Objectives:
This study examined the role of IgM anti-PC and incident CVD among women, where less is known than among men in the general population.
Methods:
In a total of 932 women, age 66 ± 6 years at baseline, from the population-based Swedish Mammography Cohort, IgM anti-PC levels of sera were measured using Enzyme Linked Immunosorbent assay. Prospective associations with any first CVD, ischemic heart disease (IHD), myocardial infarction (MI), and ischemic stroke were assessed using Cox proportional hazard regression, generating HRs and 95% CIs. The model was adjusted for potential confounding factors.
Results:
Over the course of 16 years (13,033 person-years), we identified 113 cases of composite CVD, 69 cases of IHD, 44 cases of MI, and 50 cases of ischemic stroke. IgM anti-PC was statistically significantly inversely associated with risk of CVD, IHD, and MI, but not with ischemic stroke. Comparing the highest tertile with lowest, we observed multivariable-adjusted HR of 0.27 (95% CI: 0.11-0.68; P trend <0.01) for MI.
Conclusions:
IgM anti-PC may play an active role in inhibition of CVD development in women, especially MI. Furthermore, IgM anti-PC levels may play a role in identifying those at risk.
More Related Videos
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Related Concept Videos
Synthesis of Phosphatidylcholine in the ER Membrane
The major components of all eukaryotic cell...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...